
About AccuLine
AccuLine is a Healthcare company based in Israel founded in 2022 by Benny Shani, Moshe Barel, Shai Revzen, and Aaron Frimerman. Diagnostic device for early coronary artery disease detection is developed. AccuLine has raised $4.2 million across 2 funding rounds from investors including Mayo Clinic, Maccabi Health Services and eHealth Ventures. Its chief executive, as recorded, is Moshe Barel. AccuLine offers products and services including CORA. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
AccuLine was founded in 2022 in Israel within the medical technology sector. A smart diagnostic device named CORA is being developed, incorporating machine-learning algorithms to enable early detection of coronary artery disease. Operations focus on advancing non-invasive health diagnostics, with core activities centered in device innovation and clinical application testing. The companys efforts are directed toward improving cardiovascular screening accessibility in healthcare settings.
- Headquarters Israel
- Founders Benny Shani, Moshe Barel, Shai Revzen, Aaron Frimerman
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website acculine-medical.com
- Social LinkedIn
- Total Equity Funding$4.2M (USD)
in 2 rounds
- InvestorsMayo Clinic
& 2 more
Products & Services of AccuLine
AccuLine offers a comprehensive portfolio of products and services, including CORA.
Assesses coronary artery disease risk using AI and vital signs quickly.
Funding Insights of AccuLine
AccuLine has successfully raised a total of $4.2M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.2M
- Total Rounds 2
- First Round $4.2M
(Jul 2024)
- Investors Count 3
All 2 funding rounds of AccuLine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $4.2M | Seed | β | eHealth Ventures, Maccabi Health Services | |
| Jul 2024 | Grant | β | β | β |
3 investors in total: 3 institutional.
Investors in AccuLine
AccuLine has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Mayo Clinic, Maccabi Health Services and eHealth Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage digital health ventures are funded and supported. | ehv.health | Tel Aviv, Israel | ||
Membership-based healthcare services are offered for discovery and management. | 1940 | maccabi4u.co.il | Netanya, Israel | |
General medical clinics are operated throughout the United States. | 1864 | mayoclinic.org | United States |
Investor details for AccuLine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AccuLine
4 people are tracked at AccuLine (4 in leadership).
| Name | Role | Group |
|---|---|---|
Benny Shani | Co-Founder | Leadership |
Moshe Barel | Co-Founder & CEO | Leadership |
Shai Revzen | Co-Founder | Leadership |
Aaron Frimerman | Co-Founder | Leadership |
Complete people profiles for AccuLine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AccuLine
2 dated milestones of AccuLine across 2 years, from founding to its latest funding, stage changes and deals.
- Founded AccuLine is founded.
- Funding First funding round of $4.2M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acculine
Complete news archive for AccuLine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AccuLine
AccuLine was founded in 2022 and raised its 1st funding round 2 years after it was founded.
AccuLine is headquartered in Israel.
Moshe Barel is the CEO of AccuLine, as recorded in our data. They have also founded this company.
AccuLine is a funded company, having raised a total of $4.2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.2M, raised on Jul 2024.
AccuLine was founded in 2022 in Israel within the medical technology sector. A smart diagnostic device named CORA is being developed, incorporating machine-learning algorithms to enable early detection of coronary artery disease. Operations focus on advancing non-invasive health diagnostics, with core activities centered in device innovation and clinical application testing. The companys efforts are directed toward improving cardiovascular screening accessibility in healthcare settings.
AccuLine offers CORA.
AccuLine has 3 investors. Key investors include Mayo Clinic, Maccabi Health Services, and eHealth Ventures.
